This proposal examines whether lipoxgenase (LO) products of arachidonic acid metabolism mediate the vasoconstrictor effect of angiotensin II (AII). This notion is based on findings that LO products are obligatory mediators of AII-induced adrenal aldosterone secretion and their inhibition decreases the vascular pressor response to AII. Initial studies will focus on the dose response relation of several LO inhibitors on the attenuation of the in vitro contractile responses to AII, norepinephrine and KCI in isolated intact and de-endothelialized rat femoral artery strips and in the mesenteric and hind limb circulations. Simultaneous measurements by HPLC and RIA of the LO products 12- and 15-hydroxyeicosotetranoic acid (HETE) will be done on femoral arteries under the experimental conditions described above. Further studies will be examine the direct effect of HETEs on contractility by addition to femoral vessels alone and to arteries treated with AII and LO blockers. The above studies should show if LO pathway products are authentic metabolites in vascular tissue and if they have a role in mediating the vascular effects of AII. To elucidate the site of HETE production the ability of AII to stimulate HETEs in smooth muscle and endothelial cells will be studied in separate and combined tissue culture systems. AII cellular action involves changes in intracellular calcium (Cai++) and inositol triphosphate (IP3). The project will also examine in cultured vascular smooth muscle cells. (VSMC) whether 12- and 15-HETE stimulate Cai++ and IP3 and if LO blockade diminishes the AII-induced rise in Cai++. These intracellular calcium mobilization using several probes to elucidate mechanisms of HETE action on second messengers. These studies may introduce the exciting prospect of applying LO inhibitors to modulate tissue responses to AII in research and clinical medicine.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Schools of Medicine
Los Angeles
United States
Zip Code
Nyby, Michael D; Hori, Mark T; Ormsby, Bernard et al. (2003) Eicosapentaenoic acid inhibits Ca2+ mobilization and PKC activity in vascular smooth muscle cells. Am J Hypertens 16:708-14
Kanda, H; Hori, M T; Golub, M S et al. (2001) Inhibitors of arachidonic acid metabolism have variable effects on calcium signaling pathways. Am J Hypertens 14:248-53
Golub, M S; Chang, C T; Tuck, M L et al. (1998) Evidence for increased functional vascular Na+/K+ pump activity in the obese Zucker rat. Hypertens Res 21:283-8
Sasaki, M; Hori, M T; Hino, T et al. (1997) Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am J Hypertens 10:371-8
Nyby, M D; Sasaki, M; Ideguchi, Y et al. (1996) Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation. J Pharmacol Exp Ther 278:503-9
Corry, D B; Tuck, M L; Nicholas, S et al. (1993) Increased Na/H antiport activity and abundance in uremic red blood cells. Kidney Int 44:574-8
Saito, F; Hori, M T; Ideguchi, Y et al. (1992) 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension 20:138-43
Berger, M E; Golub, M S; Chang, C T et al. (1992) Flavonoid potentiation of contractile responses in rat blood vessels. J Pharmacol Exp Ther 263:78-83